Fifth Third Wealth Advisors LLC

Position in BMY — Bristol Myers Squibb Co

CIK 1899030 Cincinnati, OH

Position in BMY

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$3,769,097

-$790,448 QoQ

Shares Held

65,413

-13.0% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.17%

of 13F equity value

Holder Rank

#626

of 2,506 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Fifth Third Wealth Advisors LLC holds $84,923,860 across 10 Drug Manufacturers - General names. BMY ranks #7 (4.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	25,068	$30,067,313
2	JNJ	Johnson & Johnson	57,925	$14,711,212
3	ABBV	AbbVie Inc.	51,073	$12,852,009
4	MRK	Merck & Co., Inc.	73,198	$9,405,943
5	PFE	Pfizer Inc	205,404	$4,946,128
6	GILD	Gilead Sciences, Inc.	33,341	$4,212,301
7	BMY	Bristol Myers Squibb Co This page	65,413	$3,769,097
8	AMGN	Amgen Inc	9,260	$3,353,231

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,769,097	65,413	-13.0%	Shares	Sole	2026-07-17
2026-03-31	$4,559,545	75,178	+47.2%	Shares	Sole	2026-04-20
2025-12-31	$2,755,309	51,081	+8.7%	Shares	Sole	2026-01-15
2025-09-30	$2,119,113	46,987	+10.2%	Shares	Sole	2025-10-21
2025-06-30	$1,973,157	42,626	+180.9%	Shares	Sole	2025-07-25
2025-03-31	$925,401	15,173	-4.7%	Shares	Sole	2025-04-08
2024-12-31	$900,887	15,928	+6.4%	Shares	Sole	2025-01-14
2024-09-30	$774,444	14,968	+1.2%	Shares	Sole	2024-11-07
2024-06-30	$614,436	14,795	+82.6%	Shares	Sole	2024-07-23
2024-03-31	$439,425	8,103	+45.8%	Shares	Sole	2024-04-16
2023-12-31	$285,078	5,556	+11.9%	Shares	Sole	2024-01-08
2023-09-30	$288,284	4,967	+58.3%	Shares	Sole	2023-10-17
2023-06-30	$200,611	3,137	—	Shares	Sole	2023-07-25
No filing history on record for this holder in this stock.